Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
FATE holding history
Fate Therapeutics Inc in every 13F filed by Boxer Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FATE overviewAll 13F holders of FATEFull Q4 2024 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −4,960,910−100.0% | Sold out | Holders |
| Q3 2024 | 4,960,910 | $17.4M | 0.9% | −3,255,000−39.6% | Reduced | Holders |
| Q2 2024 | 8,215,910 | $26.9M | 1.4% | 00.0% | Unchanged | Holders |
| Q1 2024 | 8,215,910 | $60.3M | 3.0% | +7,715,910+1,543.2% | Added | Holders |
| Q4 2023 | 500,000 | $1.87M | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 500,000 | $1.06M | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 500,000 | $2.38M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 500,000 | $2.85M | 0.1% | −750,000−60.0% | Reduced | Holders |
| Q4 2022 | 1,250,000 | $12.6M | 0.7% | +900,000+257.1% | Added | Holders |
| Q3 2022 | 350,000 | $7.84M | 0.4% | −150,000−30.0% | Reduced | Holders |
| Q2 2022 | 500,000 | $12.4M | 0.8% | 00.0% | Unchanged | Holders |
| Q1 2022 | 500,000 | $19.4M | 1.0% | 00.0% | Unchanged | Holders |
| Q4 2021 | 500,000 | $29.3M | 1.2% | +500,000 | New | Holders |